NCBE inhibitors, short for Sodium Bicarbonate Cotransporter Inhibitors, belong to a chemical class of compounds that play a crucial role in regulating the movement of bicarbonate ions across cellular membranes. These inhibitors target the NCBE, which is a member of the SLC4 family of bicarbonate transporters. The SLC4 family includes several transporters that are responsible for regulating intracellular pH and ion balance in various tissues and cells throughout the body. NCBE, in particular, is found in various tissues, including the brain, heart, and kidneys, where it is involved in transporting bicarbonate ions (HCO3-) across the cell membrane. This transporter is essential for maintaining acid-base balance, pH homeostasis, and cellular function.
NCBE inhibitors work by interfering with the normal function of this transporter, ultimately affecting bicarbonate ion transport. By inhibiting NCBE, these compounds can disrupt the movement of bicarbonate ions, which may have significant implications in various physiological processes. NCBE inhibitors have the potential to impact areas such as cellular pH regulation, electrolyte balance, and even cell signaling pathways. Understanding the intricate details of these inhibitors' effects on bicarbonate transport is crucial for elucidating their broader physiological implications and potentially unveiling novel insights into cellular and tissue function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $105.00 $362.00 | ||
Interferes with neuronal ion exchange and may indirectly affect SLC4A10 activity in the brain. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $79.00 $174.00 $425.00 $530.00 $866.00 $1450.00 $2200.00 | 1 | |
Carbonic anhydrase inhibitor, alters pH balance and bicarbonate transport, potentially altering SLC4A10 activity. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $40.00 | ||
Loop diuretic that inhibits NKCC2, could alter chloride homeostasis and indirectly affect SLC4A10. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $54.00 $235.00 $326.00 $551.00 $969.00 | ||
Thiazide diuretic, impacts sodium transport which can indirectly modify SLC4A10 function due to ionic changes. | ||||||
Methazolamide | 554-57-4 | sc-235615 | 1 g | $92.00 | 3 | |
Another carbonic anhydrase inhibitor that can alter bicarbonate and sodium handling, possibly affecting SLC4A10. | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | $107.00 $224.00 | 9 | |
Inhibits NKCC cotransporter, which may indirectly influence SLC4A10 activity by altering ionic gradients. | ||||||
Dorzolamide | 120279-96-1 | sc-337687 | 1 g | $960.00 | 2 | |
Carbonic anhydrase inhibitor used to lower intraocular pressure, could have an indirect effect on SLC4A10. | ||||||
Indapamide | 26807-65-8 | sc-204777 sc-204777A | 250 mg 1 g | $45.00 $63.00 | ||
Sulfonamide diuretic affecting sodium reabsorption which might indirectly interact with SLC4A10's function. | ||||||